Skip to main content
Top
Published in: Clinical & Experimental Metastasis 8/2016

01-12-2016 | Research Paper

Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions

Authors: Isabelle Matte, Clara Major Legault, Perrine Garde-Granger, Claude Laplante, Paul Bessette, Claudine Rancourt, Alain Piché

Published in: Clinical & Experimental Metastasis | Issue 8/2016

Login to get access

Abstract

Epithelial ovarian cancer (EOC) dissemination is primarily mediated by the shedding of tumor cells from the primary site into ascites where they form multicellular spheroids that rapidly lead to peritoneal carcinomatosis. While the clinical importance and fundamental role of multicellular spheroids in EOC is increasingly appreciated, the mechanisms that regulate their formation and dictate their cellular composition remain poorly characterized. To investigate these important questions, we characterized spheroids isolated from ascites of women with EOC. We found that in these spheroids, a core of mesothelial cells was encased in a shell of tumor cells. Analysis further revealed that EOC spheroids are dynamic structures of proliferating, non-proliferating and hypoxic regions. To recapitulate these in vivo findings, we developed a three-dimensional co-culture model of primary EOC and mesothelial cells. Our analysis indicated that, compared to the OVCAR3 cell line, primary EOC cells isolated from ascites as well as mesothelial cells formed compact spheroids. Analysis of heterotypic spheroid microarchitecture revealed a structure that grossly resembles the structure of spheroids isolated from ascites. Cells that formed compact spheroids had elevated expression of β1 integrin and low expression of E-cadherin. Addition of β1 integrin blocking antibody or siRNA-mediated downregulation of β1 integrin resulted in reduced tightness of the spheroids. Interestingly, the loss of MUC16 and E-cadherin expression resulted in the formation of more compact spheroids. Therefore, our findings support the heterotypic nature of spheroids from malignant EOC ascites. In addition, our data describe an unusual link between E-cadherin expression and less compact spheroids. Our data also emphasize the role of MUC16 and β1 integrin in EOC spheroid formation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Partridge EE, Barnes MN (1999) Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 49:297–320CrossRefPubMed Partridge EE, Barnes MN (1999) Epithelial ovarian cancer: prevention, diagnosis, and treatment. CA Cancer J Clin 49:297–320CrossRefPubMed
2.
4.
go back to reference Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X, Hamilton TC (2004) Focus on epithelial ovarian cancer. Cancer Cell 5:19–24CrossRefPubMed Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, Xu X, Hamilton TC (2004) Focus on epithelial ovarian cancer. Cancer Cell 5:19–24CrossRefPubMed
5.
go back to reference Shield K, Ackland ML, Ahmed N, Rice GE (2009) Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 113:143–148CrossRefPubMed Shield K, Ackland ML, Ahmed N, Rice GE (2009) Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol Oncol 113:143–148CrossRefPubMed
6.
7.
go back to reference Xu S, Yang Y, Dong L, Qiu W, Yang L, Wang X, Liu L (2014) Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer. Sci Rep 4:5646PubMed Xu S, Yang Y, Dong L, Qiu W, Yang L, Wang X, Liu L (2014) Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer. Sci Rep 4:5646PubMed
8.
go back to reference Giannakouros P, Comamala M, Matte I, Rancourt C, Piché A (2015) MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling. Am J Cancer Res 5:219–230PubMed Giannakouros P, Comamala M, Matte I, Rancourt C, Piché A (2015) MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling. Am J Cancer Res 5:219–230PubMed
9.
go back to reference Sodek KL, Ringuette MJ, Brown TJ (2009) Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 124:2060–2070CrossRefPubMed Sodek KL, Ringuette MJ, Brown TJ (2009) Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 124:2060–2070CrossRefPubMed
10.
go back to reference Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB, Morrison CD, Odunsi K (2014) Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One 9:e84941CrossRefPubMedPubMedCentral Liao J, Qian F, Tchabo N, Mhawech-Fauceglia P, Beck A, Qian Z, Wang X, Huss WJ, Lele SB, Morrison CD, Odunsi K (2014) Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One 9:e84941CrossRefPubMedPubMedCentral
11.
go back to reference Dong Y, Stephens C, Walpole C, Swedberg JE, Boyle GM, Parsons PG, McGuckin MA, Harris JM, Clements JA (2013) Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment. PLoS One 8:e57056CrossRefPubMedPubMedCentral Dong Y, Stephens C, Walpole C, Swedberg JE, Boyle GM, Parsons PG, McGuckin MA, Harris JM, Clements JA (2013) Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment. PLoS One 8:e57056CrossRefPubMedPubMedCentral
12.
go back to reference Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the α5β1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 70:2624–2633CrossRefPubMed Dong Y, Tan OL, Loessner D, Stephens C, Walpole C, Boyle GM, Parsons PG, Clements JA (2010) Kallikrein-related peptidase 7 promotes multicellular aggregation via the α5β1 integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. Cancer Res 70:2624–2633CrossRefPubMed
13.
go back to reference Makhija S, Taylor DD, Gibb RK, Gercel-Taylor C (1999) Taxol-induced bcl-2 phosphorylation in ovarian cancer monolayer and spheroids. Int J Oncol 14:515–521PubMed Makhija S, Taylor DD, Gibb RK, Gercel-Taylor C (1999) Taxol-induced bcl-2 phosphorylation in ovarian cancer monolayer and spheroids. Int J Oncol 14:515–521PubMed
14.
go back to reference Condello S, Morgan CA, Nagdas S, Cao L, Turek J, Hurley TD, Matei D (2015) B-catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene 34:2297–2308CrossRefPubMed Condello S, Morgan CA, Nagdas S, Cao L, Turek J, Hurley TD, Matei D (2015) B-catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids. Oncogene 34:2297–2308CrossRefPubMed
15.
16.
go back to reference Matte I, Lane D, Bachvarov D, Rancourt C, Piché A (2014) Role of malignant ascites on human mesothelial cells and their gene expression profiles. BMC Cancer 14:288CrossRefPubMedPubMedCentral Matte I, Lane D, Bachvarov D, Rancourt C, Piché A (2014) Role of malignant ascites on human mesothelial cells and their gene expression profiles. BMC Cancer 14:288CrossRefPubMedPubMedCentral
17.
go back to reference Matte I, Lane D, Laplante C, Garde-Granger P, Rancourt C, Piché A (2015) Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Int J Cancer 137:289–298CrossRefPubMed Matte I, Lane D, Laplante C, Garde-Granger P, Rancourt C, Piché A (2015) Ovarian cancer ascites enhance the migration of patient-derived peritoneal mesothelial cells via cMet pathway through HGF-dependent and -independent mechanisms. Int J Cancer 137:289–298CrossRefPubMed
18.
go back to reference Caicedo-Carvajal CE, Liu Q, Goy A, Pecora A, Suh KS (2012) Three-dimensional cell culture models for biomarker discoveries and cancer research. Transl Med S1:005 Caicedo-Carvajal CE, Liu Q, Goy A, Pecora A, Suh KS (2012) Three-dimensional cell culture models for biomarker discoveries and cancer research. Transl Med S1:005
19.
go back to reference Lane D, Matte I, Rancourt C, Piché A (2012) Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. J Ovar Res 5:34CrossRef Lane D, Matte I, Rancourt C, Piché A (2012) Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. J Ovar Res 5:34CrossRef
20.
go back to reference Boivin M, Lane D, Beaudin J, Piché A, Rancourt C (2009) CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecol Oncol 115:407–413CrossRefPubMed Boivin M, Lane D, Beaudin J, Piché A, Rancourt C (2009) CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. Gynecol Oncol 115:407–413CrossRefPubMed
21.
go back to reference Thériault C, Pinard M, Comamala M, Migneault M, Beaudin J, Matte I, Boivin M, Piché A, Rancourt C (2011) MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol Oncol 121:434–443CrossRefPubMed Thériault C, Pinard M, Comamala M, Migneault M, Beaudin J, Matte I, Boivin M, Piché A, Rancourt C (2011) MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecol Oncol 121:434–443CrossRefPubMed
22.
go back to reference Matte I, Lane D, Boivin M, Rancourt C, Piché A (2014) MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL R2 expression and increasing c-FLIP expression. BMC Cancer 14:234CrossRefPubMedPubMedCentral Matte I, Lane D, Boivin M, Rancourt C, Piché A (2014) MUC16 mucin (CA125) attenuates TRAIL-induced apoptosis by decreasing TRAIL R2 expression and increasing c-FLIP expression. BMC Cancer 14:234CrossRefPubMedPubMedCentral
23.
go back to reference Shepherd TG, Thériault BL, Campbell EJ, Nachtigal MW (2006) Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc 1:2643–2649CrossRefPubMed Shepherd TG, Thériault BL, Campbell EJ, Nachtigal MW (2006) Primary culture of ovarian surface epithelial cells and ascites-derived ovarian cancer cells from patients. Nat Protoc 1:2643–2649CrossRefPubMed
24.
go back to reference Zietarska M, Maugard C, Filali-Mouhim A, Alam-Fahmy M, Tonin PN, Provencher DM, Mes-Masson AM (2007) Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Mol Carcinog 46:872–885CrossRefPubMed Zietarska M, Maugard C, Filali-Mouhim A, Alam-Fahmy M, Tonin PN, Provencher DM, Mes-Masson AM (2007) Molecular description of a 3D in vitro model for the study of epithelial ovarian cancer (EOC). Mol Carcinog 46:872–885CrossRefPubMed
25.
go back to reference Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168–181CrossRefPubMed Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168–181CrossRefPubMed
26.
go back to reference Comamala M, Pinard M, Thériault C, Matte I, Albert A, Boivin M, Beaudin J, Piché A, Rancourt C (2011) Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signaling in NIH:OVCAR3 ovarian carcinoma cells. Br J Cancer 104:989–999CrossRefPubMedPubMedCentral Comamala M, Pinard M, Thériault C, Matte I, Albert A, Boivin M, Beaudin J, Piché A, Rancourt C (2011) Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signaling in NIH:OVCAR3 ovarian carcinoma cells. Br J Cancer 104:989–999CrossRefPubMedPubMedCentral
27.
go back to reference Chaturvedi P, Gilkes DM, Wong CC, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semanza GL (2013) Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Investig 123:189–205CrossRefPubMed Chaturvedi P, Gilkes DM, Wong CC, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semanza GL (2013) Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Investig 123:189–205CrossRefPubMed
28.
go back to reference Barbolina MV, Burkhatter RJ, Stack MS (2011) Diverse mechanisms for activation of Wnt signalling in the ovarian tumor environment. Biochem J 437:1–12CrossRefPubMedPubMedCentral Barbolina MV, Burkhatter RJ, Stack MS (2011) Diverse mechanisms for activation of Wnt signalling in the ovarian tumor environment. Biochem J 437:1–12CrossRefPubMedPubMedCentral
29.
go back to reference Tsukada T, Fushhida S, Harada S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, Ohta T (2012) The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer. Int J Oncol 41:476–482PubMedPubMedCentral Tsukada T, Fushhida S, Harada S, Yagi Y, Kinoshita J, Oyama K, Tajima H, Fujita H, Ninomiya I, Fujimura T, Ohta T (2012) The role of human peritoneal mesothelial cells in the fibrosis and progression of gastric cancer. Int J Oncol 41:476–482PubMedPubMedCentral
30.
go back to reference Lee ES, Leong AS, Kim YS, Lee JH, Kim I, Ahn GH, Kim HS, Chun YK (2006) Calretinin, CD34, and alpha smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. Mod Pathol 19:364–372CrossRefPubMed Lee ES, Leong AS, Kim YS, Lee JH, Kim I, Ahn GH, Kim HS, Chun YK (2006) Calretinin, CD34, and alpha smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. Mod Pathol 19:364–372CrossRefPubMed
31.
go back to reference Thoma GR, Zimmermann M, Agarkova I, Kelm JM, Krek W (2014) 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69–70:29–41CrossRefPubMed Thoma GR, Zimmermann M, Agarkova I, Kelm JM, Krek W (2014) 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Adv Drug Deliv Rev 69–70:29–41CrossRefPubMed
32.
go back to reference Liu H, Radisky DC, Wang F, Bissell MJ (2004) Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 164:603–612CrossRefPubMedPubMedCentral Liu H, Radisky DC, Wang F, Bissell MJ (2004) Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells. J Cell Biol 164:603–612CrossRefPubMedPubMedCentral
33.
34.
go back to reference Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Peterson OW (2002) Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94:1494–1503CrossRefPubMedPubMedCentral Wang F, Hansen RK, Radisky D, Yoneda T, Barcellos-Hoff MH, Peterson OW (2002) Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94:1494–1503CrossRefPubMedPubMedCentral
35.
go back to reference Dorst N, Oberringer M, Grasser U, Pohlemann T, Metzher W (2014) Analysis of cellular composition of co-culture spheroids. Ann Anat 196:303–311CrossRefPubMed Dorst N, Oberringer M, Grasser U, Pohlemann T, Metzher W (2014) Analysis of cellular composition of co-culture spheroids. Ann Anat 196:303–311CrossRefPubMed
36.
go back to reference Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber JM, Vogel GF, Blumer M, Koeck S, Pechriggl EJ, Kelm JM, Hilbe W, Zwierzina H (2014) Development of an innovative 3D cell culture system to study tumor – stroma interactions in non-small cell lung cancer cells. PLoS One 9:e92511CrossRefPubMedPubMedCentral Amann A, Zwierzina M, Gamerith G, Bitsche M, Huber JM, Vogel GF, Blumer M, Koeck S, Pechriggl EJ, Kelm JM, Hilbe W, Zwierzina H (2014) Development of an innovative 3D cell culture system to study tumor – stroma interactions in non-small cell lung cancer cells. PLoS One 9:e92511CrossRefPubMedPubMedCentral
37.
go back to reference Ivascu A, Kubbies M (2007) Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31:1403–1413PubMed Ivascu A, Kubbies M (2007) Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31:1403–1413PubMed
38.
go back to reference Foty RA, Steinberg MS (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48:397–409CrossRefPubMed Foty RA, Steinberg MS (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48:397–409CrossRefPubMed
39.
go back to reference Sawada K, Mitra AK, Radhabi R, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E (2008) Loss of E-cadherin promotes ovarian cancer metastasis via α5-integrin, which is a therapeutic target. Cancer Res 68:2329–2339CrossRefPubMedPubMedCentral Sawada K, Mitra AK, Radhabi R, Bhaskar V, Kistner EO, Tretiakova M, Jagadeeswaran S, Montag A, Becker A, Kenny HA, Peter ME, Ramakrishnan V, Yamada SD, Lengyel E (2008) Loss of E-cadherin promotes ovarian cancer metastasis via α5-integrin, which is a therapeutic target. Cancer Res 68:2329–2339CrossRefPubMedPubMedCentral
40.
go back to reference Veatch AL, Carson LF, Ramakrishnan S (1994) Differential expression of cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 58:393–399CrossRefPubMed Veatch AL, Carson LF, Ramakrishnan S (1994) Differential expression of cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells. Int J Cancer 58:393–399CrossRefPubMed
41.
go back to reference Lin RZ, Chou LF, Chien CC, Chang HY (2006) Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin. Cell Tissue Res 324:411–422CrossRefPubMed Lin RZ, Chou LF, Chien CC, Chang HY (2006) Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin. Cell Tissue Res 324:411–422CrossRefPubMed
42.
go back to reference Rafehi S, Ramos YR, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG (2016) TFGβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer 23:147–159CrossRefPubMed Rafehi S, Ramos YR, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG (2016) TFGβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids. Endocr Relat Cancer 23:147–159CrossRefPubMed
43.
go back to reference Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ (2012) Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev 31:397–414CrossRefPubMedPubMedCentral Sodek KL, Murphy KJ, Brown TJ, Ringuette MJ (2012) Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis. Cancer Metastasis Rev 31:397–414CrossRefPubMedPubMedCentral
44.
go back to reference Allen HJ, Porter C, Gamarra M, Piver MS, Johnson EA (1987) Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. Exp Cell Biol 55:194–208PubMed Allen HJ, Porter C, Gamarra M, Piver MS, Johnson EA (1987) Isolation and morphologic characterization of human ovarian carcinoma cell clusters present in effusions. Exp Cell Biol 55:194–208PubMed
45.
go back to reference Pomo JM, Taylor RM, Gullapalli RR (2016) Influence of TP53 and CDH1 genes in hepatocellular cancer spheroid formation and culture: a model system to understand cancer cell growth mechanics. Cancer Cell Int 16:44CrossRefPubMedPubMedCentral Pomo JM, Taylor RM, Gullapalli RR (2016) Influence of TP53 and CDH1 genes in hepatocellular cancer spheroid formation and culture: a model system to understand cancer cell growth mechanics. Cancer Cell Int 16:44CrossRefPubMedPubMedCentral
46.
go back to reference Bernaudo S, Salem M, Qi X, Zhou W, Zhang C, Yang W, Rosman D, Deng Z, Ye G, Yang B, Vanderhyden B, Wu Z, Peng C (2016) Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling. Oncogene. doi:10.1038/onc.2016.15 Bernaudo S, Salem M, Qi X, Zhou W, Zhang C, Yang W, Rosman D, Deng Z, Ye G, Yang B, Vanderhyden B, Wu Z, Peng C (2016) Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling. Oncogene. doi:10.​1038/​onc.​2016.​15
47.
go back to reference Ridgway RA, Serrels B, Mason S, Kinnaird A, Muir M, Patel H, Muller WJ, Sansom OJ, Brunton VG (2012) Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. Carcinogenesis 33:2369–2376CrossRefPubMed Ridgway RA, Serrels B, Mason S, Kinnaird A, Muir M, Patel H, Muller WJ, Sansom OJ, Brunton VG (2012) Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. Carcinogenesis 33:2369–2376CrossRefPubMed
48.
go back to reference Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK (2016) Genes Cancer 7:110–124PubMedPubMedCentral Muniyan S, Haridas D, Chugh S, Rachagani S, Lakshmanan I, Gupta S, Seshacharyulu P, Smith LM, Ponnusamy MP, Batra SK (2016) Genes Cancer 7:110–124PubMedPubMedCentral
Metadata
Title
Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions
Authors
Isabelle Matte
Clara Major Legault
Perrine Garde-Granger
Claude Laplante
Paul Bessette
Claudine Rancourt
Alain Piché
Publication date
01-12-2016
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 8/2016
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-016-9821-y

Other articles of this Issue 8/2016

Clinical & Experimental Metastasis 8/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine